Clinical Trial Applications - Approved: Filter, Search, and view applications


Clear
Extended search...

Page 10 of 14, showing 10 Applications out of 131 total, starting on record 91, ending on 100

# Protocol No Study Title Investigator(s) & Site(s) Date Approved

91.

ECCT/23/03/01   Micronutrient supplementation
    Optimizing nutrient supplementation among pregnant and reproductive age women in Kenya (Virutubisho)   
Principal Investigator(s)
1. DR. Martha Kaeni Mwangome
Site(s) in Kenya
KILIFI
 
24-07-2023 View

92.

ECCT/22/11/02   UNCPM 22120 5-FU Study
    UNCPM  22120: Safety of adjuvant, self-administered intravaginal 5-fluorouracil (5-FU) cream following cervical intraepithelial neoplasia grade 2 and 3 (CIN2/3) treatment among HIV-positive women in Kenya: A pilot study   
Principal Investigator(s)
1. Elizabeth Anne Bukusi
2. Chemtai Mungo
Site(s) in Kenya
Jaramogi Oginga Odinga Teaching and Referral Hospital (JOOTRH)
 
01-03-2023 View

93.

ECCT/23/05/01   A5356
    A Phase II, Prospective, Randomized, Multicenter Trial to Evaluate the Efficacy and Safety/Tolerability of Two Linezolid Dosing Strategies in Combination with a Short Course Regimen for the Treatment of Drug-Resistant Pulmonary Tuberculosis   
Principal Investigator(s)
1. Abraham Mosigisi Siika
Site(s) in Kenya
MOI UNIVERSITY CLINICAL RESEARCH CENTRE
 
06-03-2024 View

94.

ECCT/23/05/06   Sildenafil citrate to improve
    Sildenafil citrate to improve maternal and neonatal outcomes in low-resource settings:    a randomized feasibility trial   
Principal Investigator(s)
1. Nora Switchenko
Site(s) in Kenya
NAKURU COUNTY REFERRAL AND TEACHING HOSPITAL
 
05-07-2024 View

95.

ECCT/18/07/02   CONRAD RING
    Phase IIa, 90-Day Safety, Adherence, and Acceptability Study of Intravaginal Rings Releasing Tenofovir with and without Levonorgestrel among Women in Western Kenya   
Principal Investigator(s)
1. DR. NELLY RWAMBA MUGO
Site(s) in Kenya
KEMRI CRC
 
22-09-2018 View

96.

ECCT/26/02/07   IMPAACT 2024
    Phase I/II Dose Finding, Safety and Tolerability Study of Daily Rifapentine Combined with Isoniazid (1HP) for Tuberculosis Prevention in Children Less Than 13 Years of Age with and without HIV   
Principal Investigator(s)
1. LUCY Chepkurui Koech
Site(s) in Kenya
Kenya Medical Research Institute/Walter Reed Project(KEMRI/WRP)
 
27-08-2026 View

97.

ECCT/18/04/03   ShangRing vs. Mogen Clamp for EIMC
    Evaluation of the ShangRing vs. Mogen Clamp for Early Infant Male Circumcision in sub-Saharan Africa       
Principal Investigator(s)
1. Richard Lee
2. Mark Barone
Site(s) in Kenya
1. Homa Bay Teaching and Referral Hospital (Homa Bay county)
2. Jaramogi Oginga Odinga Teaching and Referral Hospital (Kisumu county)
 
10-12-2018 View

98.

ECCT/20/08/02   ALIVE study
    Evaluation of the effectiveness of IVERMECTIN co-formulation vs ALBENDAZOLE for treatment of for the Treatment of Soil-Transmitted Helminth Infections (Trichuris trichiura, hookworm, Strongyloides stercoralis) in school aged children and Young Adult Subjects (ALIVE Study)   
Principal Investigator(s)
1. Charles Mwandawiro
Site(s) in Kenya
Kwale
 
12-01-2021 View

99.

ECCT/17/09/03   A5354
    Effect of Antiretroviral Treatment Initiated During Acute HIV-1 Infection on Measures of HIV-1 Persistence and on HIV-1-Specific Immune Responses   
Principal Investigator(s)
1. Deborah Langat
Site(s) in Kenya
Kenya Medical Research Institute Walter Reed Project Clinical Research Centre
 
14-11-2017 View

100.

ECCT/17/09/04   A5354
    A5354       Effect of Antiretroviral Treatment Initiated During Acute HIV-1 Infection on Measures of HIV-1 Persistence and on HIV-1-Specific Immune Responses   
Principal Investigator(s)
1. Brian Baker
Site(s) in Kenya
KISUMU CRS
 
21-03-2018 View